Global web icon
drugs.com
https://www.drugs.com/austedo.html
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Global web icon
webmd.com
https://www.webmd.com/drugs/2/drug-173487/austedo-…
Austedo (deutetrabenazine) - Uses, Side Effects, and More
Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Global web icon
austedo.com
https://www.austedo.com/
Learn About AUSTEDO® XR (deutetrabenazine) tablets.
AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea. See safety info including Boxed Warning.
Global web icon
medicalnewstoday.com
https://www.medicalnewstoday.com/articles/drugs-au…
Austedo dosage: Form, strengths, how to take, and more
Several factors can affect your Austedo dosage, including switching from tetrabenazine, other medications you take, side effects, and how you respond to treatment.
Global web icon
fda.gov
https://www.accessdata.fda.gov/drugsatfda_docs/lab…
label - Food and Drug Administration
AUSTEDO XR extended-release tablets and AUSTEDO tablets are formulated with deutetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor for oral administration.
Global web icon
nih.gov
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm…
DailyMed - AUSTEDO- deutetrabenazine tablet, coated AUSTEDO ...
AUSTEDO XR extended-release tablets and AUSTEDO tablets are formulated with deutetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor for oral administration.
Global web icon
clevelandclinic.org
https://my.clevelandclinic.org/health/drugs/19599-…
Austedo (Deutetrabenazine): Uses & Side Effects - Cleveland Clinic
Deutetrabenazine Tablets Austedo® is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington’s disease. It comes in a tablet form that you can take by mouth with a glass of water as directed.
Global web icon
austedohcp.com
https://www.austedohcp.com/
AUSTEDO XR® (deutetrabenazine) extended-release tablets | Healthcare ...
The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. Adverse reactions with AUSTEDO XR extended-release tablets are expected to be similar to AUSTEDO tablets. Please see full Prescribing Information, including Boxed Warning.
Global web icon
fda.gov
https://www.accessdata.fda.gov/drugsatfda_docs/lab…
AUSTEDO (deutetrabenazine) tablets - Food and Drug Administration
AUSTEDO tablets contain 6 mg, 9 mg, or 12 mg deutetrabenazine, and the following inactive ingredients: ammonium hydroxide, black iron oxide, n-butyl alcohol, butylated hydroxyanisole, butylated hydroxytoluene, magnesium stearate, mannitol, microcrystalline cellulose, polyethylene glycol, polyethylene oxide, polysorbate 80, polyvinyl alcohol ...
Global web icon
drugs.com
https://www.drugs.com/tips/austedo-patient-tips
Austedo Patient Tips: 7 things you should know - Drugs.com
Austedo is an oral tablet that treats involuntary movements in Huntington's disease and tardive dyskinesia by blocking VMAT2, a protein controlling nerve signal transmission. Starting at 6 mg daily, doses may increase weekly to 48 mg maximum. Common side effects include extreme drowsiness, diarrhea, dry mouth, nasal congestion, and fatigue.